![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 40, 28075-28078, October 1, 1999
From the Interferon-
COMMUNICATION
p48 (ISGF-3
) Is Involved in Interferon-
-induced
Suppression of Hepatitis B Virus Enhancer-1 Activity
,
,
,
Health Research Center and the
Department of Clinical Pharmacology,
(IFN-
) suppresses hepatitis B
virus (HBV) gene expression by reducing its enhancer-1 activity.
IFN-
induces transcription factors, interferon-stimulated gene
factor 3 (ISGF3), and interferon regulatory factor-1 (IRF-1), which
activate interferon-inducible gene expression through binding to the
interferon-stimulated regulatory element (ISRE) "AGTTTCNNTTTCNC" in
the gene promoters. We found the ISRE-like sequence
"AGGCTTTCACTTTCTC" in the HBV enhancer-1 region and elucidated the
role of this sequence. Gel mobility shift assay showed binding of
in vitro translated IRF-1 and in vitro
translated p48 (ISGF3-
), which is a component of ISGF3 to this
sequence. However, nuclear extracts binding to this sequence from human
hepatoma cells (HuH-7) treated with IFN-
contained only the protein
consisted of p48. In transfection experiments, IFN-
suppressed the
HBV enhancer-1 activity, and overexpression of p48 enhanced this
inhibitory effect. Both mutation and deletion of the ISRE-like sequence
in the HBV enhancer-1 region reduced the suppressive effect of IFN-
.
Our results suggest that the ISRE-like sequence in the HBV enhancer-1
can interact with the protein containing p48 and mediate the
IFN-
-induced suppression of the enhancer activity.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. F. Alcantara, H. Tang, and A. McLachlan Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome Nucleic Acids Res., May 1, 2002; 30(9): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rang, M. Bruns, T. Heise, and H. Will Antiviral Activity of Interferon-alpha against Hepatitis B Virus Can Be Studied in Non-hepatic Cells and Is Independent of MxA J. Biol. Chem., March 1, 2002; 277(10): 7645 - 7647. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Samuel Antiviral Actions of Interferons Clin. Microbiol. Rev., October 1, 2001; 14(4): 778 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rang, T. Heise, and H. Will Lack of a Role of the Interferon-stimulated Response Element-like Region in Interferon alpha -induced Suppression of Hepatitis B Virus in Vitro J. Biol. Chem., January 26, 2001; 276(5): 3531 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiao, L. Wang, X. Yang, T. Chen, D. Hodge, P. F. Johnson, and W. Farrar CCAAT/Enhancer-binding Protein beta Mediates Interferon-gamma -induced p48 (ISGF3-gamma ) Gene Transcription in Human Monocytic Cells J. Biol. Chem., June 22, 2001; 276(26): 23275 - 23281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |